Vasculitishttps://en.wikipedia.org/wiki/Vasculitis
Vasculitis o se vaega o fa'aletonu e fa'aleagaina ai a'a toto e ala i le mumū. Vasculitis e mafai ona fa'avasegaina i le mafua'aga, le nofoaga, le ituaiga va'a po'o le tele o le va'a. E mana'omia su'esu'ega a le falesu'esu'e ma le biopsy o le pa'u e su'e ai mafua'aga. O togafitiga e masani lava ona faʻatatau i le taofi o le mumū ma le taofiofia o le tino puipuia. E masani lava, o corticosteroids pei ole prednisone e faʻaaogaina.

Suesuega
Vasculitis fa'atapula'a ile pa'u e mafai ona fa'aleleia ile taimi. Ae ui i lea, e mafai ona faia suʻega toto ma urine e iloa ai faʻafitauli faʻapitoa poʻo le autoimmune.

Togafitiga - Vailaau OTC
Afai e gata le vasculitis i le paʻu e aunoa ma se osofaʻiga o isi totoga, e mafai ona faʻaaogaina se suauʻu steroid.
#OTC steroid ointment
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
  • O isi fa'alavelave fa'aletino (fa'ama'i autoimmune) e a'afia ai le vasculitis e tatau ona fa'ate'aina.
  • Ole ata masani lea ole vasculitis ole vae. E mafai ona fai se su'ega o le mimi e siaki ai ni faaletonu i le gaioiga o fatuga'o.
  • Livedo vadculopathy
  • Purpura
  • Henoch schonlein purpura
References An aetiological & clinicopathological study on cutaneous vasculitis 22382191 
NIH
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
 Leukocytoclastic Vasculitis 29489227 
NIH
Leukocytoclastic vasculitis ose ituaiga o fula o le pa'u e a'afia ai alātoto laiti ile vaega loloto ole pa'u. E mafai ona tupu e aunoa ma se mafuaʻaga poʻo le fesoʻotaʻi atu i faʻamaʻi, tuma, faʻamaʻi autoimmune, poʻo vailaʻau. O faʻailoga masani e aofia ai lanu mumu poʻo le lanu viole i luga o vae, aʻafiaga o vaʻa laiti, ma i le tusa ma le 30 pasene o mataupu, o isi vaega o le tino e aʻafia foi. O le tele o mataupu e fa'amama na o latou lava i totonu o nai vaiaso i masina. Togafitiga e fesuisuiaʻi e faʻatatau i le ogaoga, mai le faʻaitiitia malie o corticosteroids oral i le faʻaaogaina o isi vailaʻau e faʻaitiitia ai le mumū e aunoa ma le steroids.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.